| Joseph Allen Cook, MD | |
|
1710 Harrison St, Batesville, AR 72501-7303 | |
| (870) 262-1235 | |
| (870) 262-3170 |
| Full Name | Joseph Allen Cook |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 37 Years |
| Location | 1710 Harrison St, Batesville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972582120 | NPI | - | NPPES |
| 120441001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | N-8201 (Arkansas) | Secondary |
| 207Q00000X | Family Medicine | N-8201 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Howard Memorial Hospital | Nashville, AR | Hospital |
| Dardanelle Hospital | Dardanelle, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Flagg Emergency Group, Pllc | 5698008019 | 13 |
| Nes Kentucky Inc | 7416846076 | 14 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Correct Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20041207001183 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Arkansas Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774630 PECOS PAC ID: 3274681341 Enrollment ID: O20090501000014 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | South Arkansas Emergency Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942435458 PECOS PAC ID: 4486705720 Enrollment ID: O20090629000005 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Helena Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679705370 PECOS PAC ID: 9830245612 Enrollment ID: O20090919000027 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Harris Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659608040 PECOS PAC ID: 2365584331 Enrollment ID: O20100129000011 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Emergency Staffing Solutions Region Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689967895 PECOS PAC ID: 3375721707 Enrollment ID: O20110706000473 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Ess Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881967305 PECOS PAC ID: 6103085295 Enrollment ID: O20120308000726 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | East Arkansas Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932442985 PECOS PAC ID: 5698909067 Enrollment ID: O20131018000502 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Ess Of El Dorado, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861851131 PECOS PAC ID: 8325345432 Enrollment ID: O20160404001667 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Nes Kentucky Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902348048 PECOS PAC ID: 7416846076 Enrollment ID: O20161220000031 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Flagg Emergency Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912464405 PECOS PAC ID: 5698008019 Enrollment ID: O20190617002551 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Hcc Of El Dorado Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003578725 PECOS PAC ID: 1850789488 Enrollment ID: O20211101000418 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Ess Of Mcgehee Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639822653 PECOS PAC ID: 0749677516 Enrollment ID: O20220426000293 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Entity Name | Ies Arkansas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598488090 PECOS PAC ID: 6204207665 Enrollment ID: O20230123000050 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Allen Cook, MD 1710 Harrison St, Batesville, AR 72501-7303 Ph: (870) 262-1235 | Joseph Allen Cook, MD 1710 Harrison St, Batesville, AR 72501-7303 Ph: (870) 262-1235 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
Martha C. Nussbaum, the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago, has been awarded the 2015 Inamori Ethics Prize by the Inamori International Center for Ethics and Excellence at Case Western Reserve University.
› Verified 9 days ago
Jerrod Anderson, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 | |
Mary C Anderson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4100 Harrison St, Batesville, AR 72501 Phone: 870-307-0001 Fax: 870-307-0395 | |
Dr. Rachael D Goodwin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1993 Harrison St, Batesville, AR 72501 Phone: 870-698-9991 Fax: 870-698-0022 | |
Dr. Julia A Roulier, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St, Ste 300, Batesville, AR 72501 Phone: 870-793-1126 Fax: 870-793-1180 | |
Dr. Robert V Baker, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1215 Sidney St, Suite 300, Batesville, AR 72501 Phone: 870-793-1126 Fax: 870-793-1180 | |
Kevin Wade Falwell Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2201 Harrison St, Batesville, AR 72501 Phone: 870-307-0264 Fax: 870-307-0382 | |
Dr. William Jackson Waldrip Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St, Suite 300, Batesville, AR 72501 Phone: 870-793-1126 Fax: 870-793-1180 |